InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,475.09
(
0.27%
)
US TECH 100
19,193.20
(
-0.43%
)
Dow Jones
39,169.52
(
0.13%
)
Brent Oil
87.06
(
0.61%
)
Bitcoin
62,538.25
(
-0.50%
)
Post# of 4973444
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

garza

Send PM Follow Ignore
Followers 4
Posts 845
Boards Moderated 1
Alias Born 11/30/2008

garza

Re: None

Thursday, 02/12/2009 8:42:42 AM

Thursday, February 12, 2009 8:42:42 AM

Post# of 4973444
Just a few days until FDA approval

HEB's ( HEB ) drug Ampligen, used to treat Chronic Fatigue Syndrome, has an excellent chance of gaining FDA approval in about two weeks due to the effectiveness and safety profile observed during clinical trials.

Stock just got some profit taking from a run earlier in the week. Nice point to jump in. It's expected to run up past $1 before the announcement.

FDA Calendar:
http://3.bp.blogspot.com/_Du0YWLylHeA/SZDJjbqrA-I/AAAAAAAAA4s/5ZZF_mhlEQY/s1600-h/fdac9feb09.JPG
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up